ATE371680T1 - Polymerkonjugate - Google Patents
PolymerkonjugateInfo
- Publication number
- ATE371680T1 ATE371680T1 AT03700372T AT03700372T ATE371680T1 AT E371680 T1 ATE371680 T1 AT E371680T1 AT 03700372 T AT03700372 T AT 03700372T AT 03700372 T AT03700372 T AT 03700372T AT E371680 T1 ATE371680 T1 AT E371680T1
- Authority
- AT
- Austria
- Prior art keywords
- conjugates
- moiety
- polydispersity
- biologically active
- active compounds
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000178 monomer Substances 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- ZJXZSIYSNXKHEA-UHFFFAOYSA-N ethyl dihydrogen phosphate Chemical compound CCOP(O)(O)=O ZJXZSIYSNXKHEA-UHFFFAOYSA-N 0.000 abstract 1
- 230000000977 initiatory effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F246/00—Copolymers in which the nature of only the monomers in minority is defined
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicinal Preparation (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02250289 | 2002-01-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE371680T1 true ATE371680T1 (de) | 2007-09-15 |
Family
ID=27589157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03700372T ATE371680T1 (de) | 2002-01-16 | 2003-01-16 | Polymerkonjugate |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US8048408B2 (de) |
| EP (1) | EP1465933B1 (de) |
| AT (1) | ATE371680T1 (de) |
| DE (1) | DE60315949T2 (de) |
| ES (1) | ES2291613T3 (de) |
| WO (1) | WO2003062290A1 (de) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8048408B2 (en) | 2002-01-16 | 2011-11-01 | Biocompatibles Uk Limited | Polymer conjugates |
| AU2003217009A1 (en) | 2002-03-07 | 2003-09-16 | Biocompatibles Uk Limited | Compositions of polymers |
| AU2003214387A1 (en) * | 2002-03-07 | 2003-09-16 | Biocompatibles Uk Limited | Drug carriers comprising amphiphilic block copolymers |
| GB0301014D0 (en) * | 2003-01-16 | 2003-02-19 | Biocompatibles Ltd | Conjugation reactions |
| EP2267049A1 (de) * | 2003-02-05 | 2010-12-29 | Biocompatibles UK Limited | Blockcopolymere |
| GB0314472D0 (en) * | 2003-06-20 | 2003-07-23 | Warwick Effect Polymers Ltd | Polymer |
| US7786213B2 (en) * | 2003-10-15 | 2010-08-31 | The Regents Of The University Of California | Biomacromolecule polymer conjugates |
| EP1701940B1 (de) * | 2003-12-23 | 2008-05-28 | H.Lundbeck A/S | 2-(1h-indolylsulfanyl)-benzylaminderivate als ssri |
| JP5017107B2 (ja) * | 2004-07-06 | 2012-09-05 | ワーウィック イフェクト ポリマーズ リミテッド | ポリペプチド等と反応し得る官能基を含むリビングラジカル重合開始剤、それを用いて得られる櫛形ポリマー、それから得られるポリペプチド複合体及び薬剤 |
| AR052308A1 (es) * | 2004-07-16 | 2007-03-14 | Lundbeck & Co As H | Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto |
| US7629473B2 (en) * | 2005-06-17 | 2009-12-08 | H. Lundbeck A/S | 2-(1H-indolylsulfanyl)-aryl amine derivatives |
| AR054393A1 (es) * | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos. |
| SI1988910T1 (en) | 2006-02-28 | 2018-02-28 | Kodiak Sciences Inc. | Polymeric conjugates containing acryloyloxyethylphosphorylcholine and their preparations |
| CA2655933C (en) * | 2006-06-23 | 2014-09-09 | Alethia Biotherapeutics Inc. | Polynucleotides and polypeptide sequences involved in cancer |
| JP2008060540A (ja) * | 2006-08-03 | 2008-03-13 | Seiko Epson Corp | 電子デバイスの製造方法、電子デバイスおよび電子機器 |
| US20100056428A1 (en) | 2006-09-01 | 2010-03-04 | Novo Nordisk Health Care Ag | Modified proteins |
| EP2118150B1 (de) | 2007-02-14 | 2015-09-23 | Biocompatibles UK Limited | Derivatisierung biologischer moleküle |
| US20130189239A1 (en) | 2008-02-27 | 2013-07-25 | Novo Nordisk A/S | Conjugated Factor VIII Molecules |
| CN104829714A (zh) | 2008-11-03 | 2015-08-12 | 阿莱斯亚生物疗法股份有限公司 | 特异性地阻滞肿瘤抗原的生物活性的抗体 |
| EP2260873B1 (de) | 2009-06-08 | 2019-07-24 | Biocompatibles UK Limited | Pcylierung von proteinen |
| WO2011075185A1 (en) | 2009-12-18 | 2011-06-23 | Oligasis | Targeted drug phosphorylcholine polymer conjugates |
| EP2536753B1 (de) | 2010-02-16 | 2017-12-20 | Novo Nordisk A/S | Faktor-VIII-Moleküle mit reduzierter VWF-Bindung |
| WO2011146595A2 (en) * | 2010-05-21 | 2011-11-24 | Siemens Healthcare Diagnostics Inc. | Zwitterionic reagents |
| CA2893376A1 (en) | 2011-03-31 | 2012-10-04 | Alethia Biotherapeutics Inc. | Antibodies against kidney associated antigen 1 and antigen binding fragemnts thereof |
| MX354705B (es) | 2011-09-23 | 2018-03-16 | Novo Nordisk As | Analogos de glucagon novedosos. |
| AU2013209234B2 (en) | 2012-01-09 | 2017-11-09 | Adc Therapeutics Sa | Method for treating breast cancer |
| US10035822B2 (en) * | 2012-11-15 | 2018-07-31 | Apellis Pharmaceuticals, Inc. | Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods |
| BR112015025464A2 (pt) | 2013-04-18 | 2017-10-10 | Novo Nordisk As | coagonistas do receptor de glp-1/glucagon estáveis, prolongados para uso médico |
| ES2819217T3 (es) | 2013-09-08 | 2021-04-15 | Kodiak Sciences Inc | Conjugados de polímeros iónicos dipolares y factor VIII |
| US9309336B2 (en) | 2013-11-27 | 2016-04-12 | King Fahd University Of Petroleum And Minerals | Synthesis and antiscalant behavior of a novel polyzwitterionic acid |
| JP2017525656A (ja) | 2014-06-04 | 2017-09-07 | ノヴォ ノルディスク アー/エス | 医療用のglp−1/グルカゴン受容体コアゴニスト |
| WO2015200905A2 (en) | 2014-06-28 | 2015-12-30 | Oligasis, Llc | Dual pdgf/vegf antagonists |
| EP3207128B1 (de) | 2014-10-17 | 2022-07-27 | Kodiak Sciences Inc. | Zwitterionische butyrylcholinesterasepolymerkonjugate |
| IL290457B2 (en) | 2015-12-30 | 2025-02-01 | Kodiak Sciences Inc | Antibodies and their conjugates |
| CA3092588A1 (en) | 2018-03-02 | 2019-09-06 | Kodiak Sciences Inc. | Il-6 antibodies and fusion constructs and conjugates thereof |
| CA3157509A1 (en) | 2019-10-10 | 2021-04-15 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
| US20230320994A1 (en) * | 2020-08-21 | 2023-10-12 | The Board Of Regents Of The University Of Texas System | Functional ionizable phospholipids |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260373A (en) | 1987-03-13 | 1993-11-09 | Repligen Corporation | Immobilized immunoglobulin-binding proteins |
| WO1989005305A1 (en) | 1987-12-09 | 1989-06-15 | 3I Research Exploitation Limited | Polymers and polymer-peptide conjugates |
| US5162430A (en) | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
| US5122614A (en) | 1989-04-19 | 1992-06-16 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
| SE466754B (sv) | 1990-09-13 | 1992-03-30 | Berol Nobel Ab | Saett att kovalent binda biopolymerer till hydrofila ytor |
| US5286846A (en) | 1991-06-14 | 1994-02-15 | The Government Of The United States Of America As Represented By The Dept. Of Health And Human Services | Amino acid derivative and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides |
| AU666485B2 (en) * | 1991-07-05 | 1996-02-15 | Biocompatibles Uk Limited | Polymeric surface coatings |
| JPH05220218A (ja) * | 1992-02-13 | 1993-08-31 | Norio Nakabayashi | 抗血栓性再生セルロース系膜及びその製造方法 |
| IL104734A0 (en) | 1993-02-15 | 1993-06-10 | Univ Bar Ilan | Bioactive conjugates of cellulose with amino compounds |
| US5919455A (en) | 1993-10-27 | 1999-07-06 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
| CA2204902A1 (en) * | 1994-11-30 | 1996-06-06 | Fred I. Chasalow | Phosphocholine drug derivatives |
| US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| US5763548A (en) * | 1995-03-31 | 1998-06-09 | Carnegie-Mellon University | (Co)polymers and a novel polymerization process based on atom (or group) transfer radical polymerization |
| TW517067B (en) | 1996-05-31 | 2003-01-11 | Hoffmann La Roche | Interferon conjugates |
| ATE207082T1 (de) * | 1996-06-12 | 2001-11-15 | Univ Warwick | Polymerisation-katalysator und -verfahren |
| AU4892897A (en) * | 1996-09-17 | 1998-04-14 | Amur Pharmaceuticals, Inc. | Phospholipid drug derivatives |
| US5830432A (en) * | 1997-03-31 | 1998-11-03 | Amur Pharmacuticals, Inc. | Phospholipid drug derivatives |
| EP0922446A1 (de) | 1997-12-03 | 1999-06-16 | Applied Research Systems Ars Holding N.V. | Lösungsphase Verfahrung zur ortspezifischer Herstellung von GRF-PEG Konjugaten |
| US6251382B1 (en) | 1998-04-17 | 2001-06-26 | Enzon, Inc. | Biodegradable high molecular weight polymeric linkers and their conjugates |
| US6562330B1 (en) * | 1998-11-13 | 2003-05-13 | Biocompatibles Limited | Therapeutic use of polymers |
| DE60027309T2 (de) | 1999-07-02 | 2006-08-31 | Symyx Technologies, Inc., Santa Clara | Polymerverzweigungen zur immobilisierung von molekülen auf oberflächen oder substraten, wobei die polymere wasserlösliche oder wasserdispergierbare segmente und sonden aufweisen |
| JP4883515B2 (ja) | 1999-09-08 | 2012-02-22 | ポリセリックス リミテッド | 均一分子量ポリマー |
| GB9924502D0 (en) * | 1999-10-15 | 1999-12-15 | Biocompatibles Ltd | Polymer blend materials |
| ATE266668T1 (de) | 2000-02-07 | 2004-05-15 | Biocompatibles Uk Ltd | Silizium enthaltende verbindungen hergestellt durch michael addition als monomere und macromere |
| US20040091451A1 (en) | 2000-05-29 | 2004-05-13 | Marie-Therese Charreyre | Biocompatible polymer for fixing biological ligands |
| EP1325046B1 (de) | 2000-10-06 | 2007-06-27 | Biocompatibles UK Limited | Zwitterionische polymere |
| US6652886B2 (en) | 2001-02-16 | 2003-11-25 | Expression Genetics | Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents |
| JP4577747B2 (ja) | 2001-06-05 | 2010-11-10 | 和光純薬工業株式会社 | 免疫学的測定法用凝集促進剤 |
| US6939564B2 (en) | 2001-06-08 | 2005-09-06 | Labopharm, Inc. | Water-soluble stabilized self-assembled polyelectrolytes |
| US6908963B2 (en) | 2001-10-09 | 2005-06-21 | Nektar Therapeutics Al, Corporation | Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith |
| US8048408B2 (en) | 2002-01-16 | 2011-11-01 | Biocompatibles Uk Limited | Polymer conjugates |
| AU2003217009A1 (en) | 2002-03-07 | 2003-09-16 | Biocompatibles Uk Limited | Compositions of polymers |
| AU2003214387A1 (en) | 2002-03-07 | 2003-09-16 | Biocompatibles Uk Limited | Drug carriers comprising amphiphilic block copolymers |
| GB0301014D0 (en) | 2003-01-16 | 2003-02-19 | Biocompatibles Ltd | Conjugation reactions |
| EP2267049A1 (de) | 2003-02-05 | 2010-12-29 | Biocompatibles UK Limited | Blockcopolymere |
| WO2004074345A2 (en) | 2003-02-19 | 2004-09-02 | Pharmacia Corporation | Carbonate esters of polyethylene glycol activated by means of oxalate esters |
| EP1596887B1 (de) | 2003-02-26 | 2022-03-23 | Nektar Therapeutics | Polymer-factor viii-konjugate |
| WO2005014024A2 (en) | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugates of a polymer and a protein linked by an oxime linking group |
| US7786213B2 (en) | 2003-10-15 | 2010-08-31 | The Regents Of The University Of California | Biomacromolecule polymer conjugates |
| US7179874B2 (en) | 2003-11-21 | 2007-02-20 | Chia Nan University Of Pharmacy And Science | Biodegradable cationic polymer |
| US7365127B2 (en) | 2005-02-04 | 2008-04-29 | Enzon Pharmaceuticals, Inc. | Process for the preparation of polymer conjugates |
| US20070123646A1 (en) | 2005-09-13 | 2007-05-31 | Lele Bhalchandra S | Protein-polymer conjugates and synthesis thereof |
-
2003
- 2003-01-16 US US10/501,393 patent/US8048408B2/en active Active
- 2003-01-16 EP EP03700372A patent/EP1465933B1/de not_active Expired - Lifetime
- 2003-01-16 AT AT03700372T patent/ATE371680T1/de not_active IP Right Cessation
- 2003-01-16 ES ES03700372T patent/ES2291613T3/es not_active Expired - Lifetime
- 2003-01-16 DE DE60315949T patent/DE60315949T2/de not_active Expired - Lifetime
- 2003-01-16 WO PCT/GB2003/000131 patent/WO2003062290A1/en not_active Ceased
-
2011
- 2011-09-23 US US13/243,887 patent/US8431113B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20050123501A1 (en) | 2005-06-09 |
| US8048408B2 (en) | 2011-11-01 |
| US8431113B2 (en) | 2013-04-30 |
| WO2003062290A1 (en) | 2003-07-31 |
| EP1465933B1 (de) | 2007-08-29 |
| EP1465933A1 (de) | 2004-10-13 |
| DE60315949D1 (de) | 2007-10-11 |
| DE60315949T2 (de) | 2008-06-12 |
| US20120016085A1 (en) | 2012-01-19 |
| ES2291613T3 (es) | 2008-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60315949D1 (de) | Polymerkonjugate | |
| WO2008076333A3 (en) | Polymer-drug conjugates with tether groups for controlled drug delivery | |
| CA2277164A1 (en) | Method of controlling polymer molecular weight and structure | |
| SE9504495L (sv) | Linjär blockpolymer innefattande urea- och uretangrupper, förfarande för framställning av linjära blockpolymerer samt användning av blockpolymererna som implantat | |
| WO2001030408A3 (en) | Adhesive composition over a bioactive polymerization initiator | |
| AU7025600A (en) | Uniform molecular weight polymers | |
| AU7522601A (en) | Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds | |
| WO1999029353A3 (en) | Medical devices with improved properties | |
| NO974678D0 (no) | Heterotelechelisk blokk-kopolymer og en fremgangsmåte for fremstilling derav | |
| CA2308721A1 (en) | Radio-opaque polymer biomaterials | |
| WO2000027887A3 (en) | Cross-linked hyaluronic acids and medical uses thereof | |
| BR9810289A (pt) | Processo de preparação de polìmeros em blocos, e, polìmero | |
| TNSN96141A1 (fr) | Formulations pharmaceutiques et procede pour leur production | |
| ZA951877B (en) | Bioactive and/or targeted dendrimer conjugates | |
| AU2685401A (en) | Synthesis method for polymers by controlled radical polymerisation with xanthates | |
| CA2294036A1 (en) | Polyallylamine polymers for treating hypercholesterolemia | |
| TW200407339A (en) | Manufacture method of living radical polymers and the polymers | |
| WO2005023294A3 (en) | Polyacetal drug conjugates as release system | |
| MX9606466A (es) | Preparacion de polimeros por polimerizacion en emulsion. | |
| WO2002010223A3 (fr) | Procede de synthese de polymeres a blocs par polymerisation radicalaire controlee | |
| ATE299897T1 (de) | Verbesserte heterozyklische kontrollmittel für polymerisationen von lebenden freien radikaltypen | |
| WO2003024939A3 (en) | Triazine compounds polymers comprising triazine structural units, and processes for the preparation of these polymers | |
| TW200726787A (en) | Copolymers produced from reacting a glycidyl ester and/or ether with a polyol and the use of the copolymers in coating compositions | |
| WO2003059382A3 (en) | Pharmaceutical compositions comprising polyanionic polymers and amphiphilic block copolymers and methods of use thereof to improve gene expression | |
| DE602004012713D1 (de) | Konjugationsreaktionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |